Although germline mutations and LOH in BRCA1 and BRCA2 genes have been detected in mutation carriers, no data currently exist concerning the role of RAD51 in sporadic prostate cancer [26, 27]. The gene discussed is BRCA2; the disease is Familial prostate cancer.